Clinically integrated networks (CINs) were first recognized by the Department of Justice (DOJ) and the Federal Trade Commission (FTC) as a way for groups of competing providers to work together to improve quality and reduce costs without running the risk of violating federal antitrust laws, but more recently have established themselves as viable alternatives to the development of more costly and complex arrangements, such as ACOs. This article explores opportunities in the new healthcare delivery paradigm created by CINs working together with health plans and payers to improve the quality and cost-effectiveness of care delivered to parties. This article is intended to be a practical guide to the best practices of CIN creation and implementation which identifies and reconciles provider and payer perspectives on this emerging area of health law.
This article originally appeared in Bloomberg BNA’s Health Law Reporter. Reprinted with permission.